The researchers behind the new AI system explained IPF is a good candidate for this type of technology, since existing ...

In the M-ACCEL trial, HU6-induced weight loss was exclusively attributed to fat loss, with no statistically significant loss in lean muscle.

Mansi Shah, MD, explains how treatment sequencing and patient eligibility guide the use of these therapies in multiple ...

Vizient's 2024 survey reveals a sharp rise in drug shortages across US health care, with pediatric care hit especially hard ...

Smartphone-based home screening significantly boosts chronic kidney disease (CKD) diagnosis and follow-up care, enhancing ...

This new meta-analysis looked to better solidify connections between atopic dermatitis and environmental irritants, such as ...

Panelists discuss how robust clinical evidence from major studies like the EPIC and OPERA trials demonstrates that ...

Panelists discuss how maintenance therapy should be tailored based on risk profiles, with standard-risk patients receiving ...

Panelists emphasize that the approval of menin inhibitors has transformed the treatment landscape for KMT2A-rearranged acute ...

Previous knowledge on melatonin use for pulmonary arterial hypertension has primarily been gathered from animal studies, with ...

Panelists discuss how autologous stem cell transplant (ASCT) deferral should be approached cautiously with concrete medical ...

Elevated NLR may no longer predict poor survival outcomes in patients with small cell lung cancer (SCLC) receiving ...